Altimmune (ALT) Revenue (2010 - 2025)
Altimmune (ALT) posted Revenue of $26,000 for Q4 2025, up 420.0% from $5,000 a year earlier and up 420.0% from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) Revenue (2010 - 2025) Analysis & Trends
For FY2025, Altimmune's Revenue came in at $41,000, up 105.0% from FY2024.
- Annual Revenue shows a five-year compound annual growth rate of -65.3% (FY2020 to FY2025).
- In prior years, Altimmune's Revenue was $20,000 in FY2024 (-95.3%), $426,000 in FY2023 (+526.5%), $68,000 in FY2022 (-98.5%) and $4.41 million in FY2021 (-46.1%).
- The Q4 2025 figure stands as the highest quarterly Revenue since Q4 2023.
- On a year-over-year basis, Revenue increased in 1 of the last eight quarters, with growth averaging 17.8%.
- The strongest year-over-year quarter for Revenue in the past five years was Q4 2025, with growth of 420.0%; the weakest was Q4 2022, with a decline of 99.2%.
- According to Business Quant data, Revenue for the three prior quarters was $5,000 (Q3 2025), $5,000 (Q2 2025) and $5,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Altimmune | 425.59 Mn | -716.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 26,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 37,000.00 |
| Sep 30, 2023 | 362,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 21,000.00 |
| Dec 31, 2022 | 26,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 32,000.00 |
| Dec 31, 2021 | 3.28 Mn |
| Sep 30, 2021 | 158,000.00 |
| Jun 30, 2021 | 137,000.00 |
| Mar 31, 2021 | 838,000.00 |
API Access
Altimmune Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();